Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?
Open Access
- 11 February 2013
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2013, 1-7
Abstract
Background and Objectives. Triple negative breast cancer (TNBC) has been shown to be generally chemosensitive. We sought to investigate the utility of mammography (MMG), ultrasonography (US), and breast magnetic resonance imaging (MRI) in predicting residual disease following neoadjuvant chemotherapy for TNBC. Methods. We identified 148 patients with 151 Stage IIII TNBC treated with neoadjuvant chemotherapy. Residual tumor size was estimated by MMG, US, and/or MRI prior to surgical intervention and compared to the subsequent pathologic residual tumor size. Data were compared using chi-squared test. Results. Of 151 tumors, 44 (29%) did not have imaging performed prior to surgical treatment. Thirty-eight (25%) tumors underwent a pathologic complete response (pCR), while 113 (75%) had residual invasive disease. The imaging modality was accurate to within 1cm of the final pathologic residual disease in 74 (69%) cases and within 2cm in 94 (88%) cases. Groups were similar with regards to patient age, race, tumor size and grade, and clinical stage (). Accuracy to within 1cm was the highest for US (83%) and the lowest for MMG (56%) (). Conclusions. Breast US and MRI were more accurate than MMG in predicting residual tumor size following neoadjuvant chemotherapy in patients with TNBC. None of the imaging modalities were predictive of a pCR.Keywords
This publication has 31 references indexed in Scilit:
- Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast CancerAmerican Journal of Roentgenology, 2005
- Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-AnalysisJNCI: Journal of the National Cancer Institute, 2005
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Ultrasonographic tissue characterization in monitoring tumor response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress).Journal of Ultrasound in Medicine, 2000
- Molecular portraits of human breast tumoursNature, 2000
- Utility of Magnetic Resonance Imaging in the Management of Breast Cancer: Evidence for Improved Preoperative StagingJournal of Clinical Oncology, 1999
- Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer.Journal of Ultrasound in Medicine, 1997
- Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.1997
- Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.Radiology, 1996
- Histologische Regression des Mammakarzinoms nach primärer (neoadjuvanter) ChemotherapieGeburtshilfe und Frauenheilkunde, 1994